USFDA clears cloud-based vital signs measuring systemOctober 8, 2019
DynoSense Corp announced that the US FDA has granted the company clearance for its patented Vital Signs Measuring System, a cloud-based vital signs measuring and recording platform.
The simple to use device is capable of capturing electrocardiogram (ECG), respiration rate (RR), oral body temperature (TEMP), functional oxygen saturation of arterial haemoglobin (SpO2), optical photoplethysmogram (PPG) for pulse rate (PR), and heart rate (HR). The wireless device communicates with any smart mobile phone operating DynoLife application or third-party customized applications and sends the raw data to the cloud for computation.
In contrast to traditional systems, the raw data is analyzed and results computed not in the device but in the cloud by an intelligent analytic (IA) engine with further capability to interpret other metrics including changes in blood pressure (BP), perfusion index (PI), different types of cardiac ailments such as atrial fibrillation (AFib), heart rate variability (HRV), and other capabilities for its IA engine that are in various stages of development and testing.
DynoSense HIPAA compliant health cloud (DYNOCLOUD) API, Software-as-a-Service (SaaS) platform, restructures data into a personalized and actionable information format to assist the care-experts to identify health conditions of concern and create individualized wellness plans.